Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

GSK Investigational Site, Pretoria

GSK Investigational Site, Budapest

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

GSK Investigational Site, Kempton Park

GSK Investigational Site, San Isidro

GSK Investigational Site, Seoul

GSK Investigational Site, Durban

GSK Investigational Site, San Juan

GSK Investigational Site, Mons

GSK Investigational Site, Cape Town

GSK Investigational Site, Stellenbosch

GSK Investigational Site, Székesfehérvár

GSK Investigational Site, A Coruña

GSK Investigational Site, Santiago de Compostela

GSK Investigational Site, Rendsburg

GSK Investigational Site, Greenville

GSK Investigational Site, Newnan

GSK Investigational Site, Atlanta

GSK Investigational Site, Jacksonville

GSK Investigational Site, DeBary

GSK Investigational Site, Miami Lakes

GSK Investigational Site, Miami

GSK Investigational Site, Miami

GSK Investigational Site, Miami

GSK Investigational Site, Miami

GSK Investigational Site, Brandon

GSK Investigational Site, Tampa

GSK Investigational Site, Tampa

GSK Investigational Site, Verona

GSK Investigational Site, Santander

GSK Investigational Site, Magdeburg

GSK Investigational Site, Cincinnati

GSK Investigational Site, Dayton

GSK Investigational Site, Valencia

GSK Investigational Site, Minot

GSK Investigational Site, Skokie

GSK Investigational Site, Chicago

GSK Investigational Site, St Louis

GSK Investigational Site, Brno

GSK Investigational Site, Lincoln

GSK Investigational Site, Ostrava

GSK Investigational Site, Oklahoma City

GSK Investigational Site, Oklahoma City

GSK Investigational Site, Plano

GSK Investigational Site, Colleyville

GSK Investigational Site, Šiauliai

GSK Investigational Site, Waco

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Tomball

GSK Investigational Site, The Woodlands

GSK Investigational Site, Baytown

GSK Investigational Site, College Station

GSK Investigational Site, San Antonio

GSK Investigational Site, San Marcos

GSK Investigational Site, Austin

GSK Investigational Site, Lubbock

GSK Investigational Site, Phoenix

GSK Investigational Site, Mesa

GSK Investigational Site, Sun City

GSK Investigational Site, Tucson

GSK Investigational Site, Whittier

GSK Investigational Site, Tujunga

GSK Investigational Site, Covina

GSK Investigational Site, Upland

GSK Investigational Site, San Diego

GSK Investigational Site, Lebanon

GSK Investigational Site, Ciudad Autonoma Buenos Aires

GSK Investigational Site, Ciudad Autonoma Buenos Aires

GSK Investigational Site, Ciudad Autonoma Buenos Aires

GSK Investigational Site, La Palta

GSK Investigational Site, Mar del Plata

GSK Investigational Site, San Nicolás de los Arroyos

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Barrie

GSK Investigational Site, Brampton

GSK Investigational Site, Trois-Rivières

GSK Investigational Site, Brno

GSK Investigational Site, Prague

GSK Investigational Site, Prague

GSK Investigational Site, Prague

GSK Investigational Site, Uherské Hradiště

GSK Investigational Site, Zlín

GSK Investigational Site, Hamburg

GSK Investigational Site, Veszprém

GSK Investigational Site, Aichi

GSK Investigational Site, Aichi

GSK Investigational Site, Aichi

GSK Investigational Site, Chiba

GSK Investigational Site, Fukuoka

GSK Investigational Site, Hokkaido

GSK Investigational Site, Hokkaido

GSK Investigational Site, Hyōgo

GSK Investigational Site, Hyōgo

GSK Investigational Site, Ibaraki

GSK Investigational Site, Kagoshima

GSK Investigational Site, Kanagawa

GSK Investigational Site, Kochi

GSK Investigational Site, Kumamoto

GSK Investigational Site, Miyagi

GSK Investigational Site, Nagasaki

GSK Investigational Site, Saitama

GSK Investigational Site, Tokyo

GSK Investigational Site, Tokyo

GSK Investigational Site, Klaipėda

GSK Investigational Site, Bialystok

GSK Investigational Site, Bydgoszcz

GSK Investigational Site, Gdansk

GSK Investigational Site, Gdynia

GSK Investigational Site, Katowice

GSK Investigational Site, Katowice

GSK Investigational Site, Krakow

GSK Investigational Site, Lodz

GSK Investigational Site, Poznan

GSK Investigational Site, Poznan

GSK Investigational Site, Sochaczew

GSK Investigational Site, Torun

GSK Investigational Site, Warsaw

GSK Investigational Site, Warsaw

GSK Investigational Site, Warsaw

GSK Investigational Site, Warsaw

GSK Investigational Site, Wroclaw

GSK Investigational Site, Pretoria

GSK Investigational Site, Incheon

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Elche

GSK Investigational Site, Romford

GSK Investigational Site, Northwood